Hdac2 antisense oligonucleotide therapy (Ionis Pharmaceuticals/Vanderbilt University)

N/A

Report date: 2025/03/20 14:45:18
NME

Base Information

Drug NameHdac2 antisense oligonucleotide therapy (Ionis Pharmaceuticals/Vanderbilt University)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionHistone deacetylase 2 inhibitors
TargetsHistone deacetylase 2
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesIonis Pharmaceuticals IncVanderbilt University
Inactive CompaniesN/A
Active IndicationsNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A